Recovery from remifentanil after plasmapheresis in a paediatric patient with myasthenia gravis.
Hepağuşlar
Hasan
H
Oztekin
Sermin
S
Capar
Emine
E
Elar
Zahide
Z
D000293:Adolescent; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D000762:Anesthesia Recovery Period; D018686:Anesthetics, Intravenous / Q000627:therapeutic use; D005260:Female; D005283:Fentanyl / Q000627:therapeutic use; D006801:Humans; D007442:Intubation, Intratracheal; D016343:Monitoring, Intraoperative; D009157:Myasthenia Gravis / Q000628:therapy*; D010880:Piperidines / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D010956:Plasmapheresis; D015742:Propofol / Q000627:therapeutic use; D000077208:Remifentanil; D013934:Thymectomy
D000701:Analgesics, Opioid; D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil; D005283:Fentanyl; D015742:Propofol